A pilot study on cost-related medication nonadherence in Ontario.
نویسندگان
چکیده
BACKGROUND Cost-related nonadherence (CRN) describes patients cutting back on their prescribed medication due to an inability to pay. CRN is influenced by drug insurance coverage plans, which vary widely among different healthcare systems. Little is known about CRN in Canada and Ontario. OBJECTIVE To develop and pilot a questionnaire about CRN. METHODS An interviewer-administered questionnaire assessing demographics, socioeconomic status, health status and health literacy, medication costs and CRN was developed for this pilot study. Participants were recruited from a general internal medicine rapid assessment outpatient clinic of a large urban teaching hospital. RESULTS Sixty patients were recruited (mean age 60.3 years; 48.3% female; mean of 5.3 prescription medications per patient). Nine patients (15%) reported some form of CRN. Unfilled prescriptions, delayed prescriptions, less frequent and smaller doses were the most common forms of CRN. Seven patients (11.7%) had no drug insurance. Patients without drug insurance were more likely to experience CRN than patients with private insurance (OR 20.70, 95% CI 1.46-292.75); government coverage also increased the likelihood of CRN compared to private coverage (OR 4.51, 95% CI 0.376-54.11). Patients spending over $100 a month out-of-pocket were more likely to experience CRN than patients spending less than $20 (OR 42.52, 95% CI 2.02-894.03). Thirty-three patients (55%) said that their physicians had not asked them about how they deal with the cost of prescriptions. CONCLUSION Based on our pilot survey, a significant minority of specialty clinic outpatients experience CRN and prescribers frequently forget to inquire whether patients can afford their medications.
منابع مشابه
Determinants of Cost-Related Nonadherence to Medications among Chronically Ill Patients in Maccabi Healthcare Services, Israel
Background: The effectiveness of value-based insurance design is based on nonadherence, which derives solely from patients’ economic constraints. Objective: Our objective was to examine the extent of cost-related nonadherence to chronic medications and to analyze its potential determinants. Methods: We conducted a telephone survey among a representative sample of Maccabi Healthcare Services chr...
متن کاملIntervening at the Intersection of Medication Adherence and Health Literacy
Medications play a prominent role in the treatment of many illnesses. Failing to adhere to prescribed medication regimens contributes to an array of poor health outcomes. In addition to the cost in terms of human suffering, the financial cost of medication nonadherence is staggering. Poor health literacy has been identified as a major cause of medication nonadherence. This paper focuses on nona...
متن کاملCost-related immunosuppressive medication nonadherence among kidney transplant recipients.
BACKGROUND AND OBJECTIVES Immunosuppressive medications are essential in preventing kidney transplant rejection. Continuous insurance coverage for outpatient immunosuppressive medications remains a major issue. The objective of this study was to establish the prevalence and consequences of cost-related immunosuppressive medication nonadherence. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS A ...
متن کاملSystematic review of the economic aspects of nonadherence to antipsychotic medication in patients with schizophrenia
PURPOSE There is strong evidence supporting the link between nonadherence to antipsychotic medication and relapse of schizophrenia. However, less obvious are the economic consequences of nonadherence. The systematic review reported here evaluated the economic aspects of nonadherence to antipsychotic medication. METHODS A systematic review of scientific papers in the PubMed MEDLINE, Embase, Ps...
متن کاملThe doughnut hole: it's about medication adherence.
The Medicare Prescription Drug, Improvement, and Modernization Act went into effect on 1 January 2006. Part of this act was the creation of Medicare Part D, a federal program to subsidize the costs of prescription drugs for Medicare beneficiaries. In 2006, the plan required beneficiaries whose total annual drug costs exceeded $2250 to pay 100% of prescription costs until they spent $5100 on med...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Journal of population therapeutics and clinical pharmacology = Journal de la therapeutique des populations et de la pharamcologie clinique
دوره 19 2 شماره
صفحات -
تاریخ انتشار 2012